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ABSTRACT 
Objectives: To investigate the relationship between bioimpedance-derived total body fat 
percentage, waist circumference (WC) and Body Mass Index (BMI) and the subsequent 
development of rheumatoid arthritis (RA). 
 
Methods: A population-based prospective cohort study among 55,037 persons enrolled into 
the Danish Diet, Cancer and Health cohort. Baseline data included anthropometric measures 
and lifestyle factors. Persons who developed RA were identified through linkage with the 
Danish National Patient Registry. The relationships between bioimpedance-derived body fat 
percentage, WC, BMI and incident RA were assessed using Cox proportional hazards 
regression models, stratifying by gender. All analyses were performed for overall RA and the 
serological subtypes: ‘seropositive RA’ and ‘other RA’. 
 
Results: A total of 210 men (37.6% seropositive RA) and 456 women (41.0% seropositive RA) 
developed RA during a median follow-up of 20.1 years. In women, overall RA risk was 10% 
higher for each 5% increment of total body fat (Hazard Ratio (HR) 1.10; 95% CI 1.02-1.18), 
5% higher for each 5cm increment of WC (HR 1.05; 95% CI 1.01-1.10) and nearly 50% higher 
in those with an obese compared to normal BMI (HR 1.46; 95% CI 1.12-1.90). These positive 
associations were also found for ‘other RA’.  In men, there were no clear associations 
between body fat percentage, WC, or BMI and RA.  No significant associations were found 
for ‘seropositive RA’ in women or men, possibly related to low sample size.  
 
Conclusions: In women, higher body fat percentage, higher waist circumference and obesity 
were associated with higher risk of RA.   
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Significance & Innovations 
 Bioelectrical impedance is more sensitive measurement of body composition than 
body mass index. 
 In women, higher bioimpedance-derived body fat percentage, waist circumference 
and obesity were associated with higher risks of developing RA. 
 No clear associations were found between body fat percentage, waist circumference 
or obesity and risk of developing RA in men. 
 Our findings imply that future investigations on potential risk factors for RA should 
be performed separately for men and women. 
 
INTRODUCTION 
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation 
of synovial joints leading to irreversible joint damage and deformity. The etiology of RA is 
considered to be multifactorial and lifestyle factors seem to play an important role for the 
development of RA in genetically susceptible hosts (1). Smoking is the best-studied and now 
well-established lifestyle risk factor for RA (2), whereas associations with other lifestyle 
factors are less clear (3–6).  
 
It is well-known that fat tissue secretes proinflammatory cytokines leading to systemic low-
grade inflammation with different fat depots contributing in distinct ways (7–9). Thus, from 
a biological point of view, excess fat tissue might be associated with the development of 
inflammatory diseases.  However, studies, examining the relationship between Body Mass 
Index (BMI) and the development of RA show conflicting results (10–23). Some studies have 
observed positive associations between BMI and risk of developing RA (11,12,15,20,21); 
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some studies found this association in sero-negative (Rheumatoid Factor (RF) or/and Anti-
Citrullinated Protein Antibody (ACPA) negative) RA (15,19,20,22); and one study found the 
association in sero-positive (RF and/or ACPA positive) RA (20).  
 
In all previous studies, BMI has been the preferred measure. However, BMI correlates only 
modestly with total body fat and does not reflect the fat distribution (24,25). Today, several 
techniques for estimating total body fat are available, including bioelectrical impedance 
analysis (BIA), a non-invasive way to estimate body fat, fat-free mass and total body water. 
BIA has been shown to be a valid and more sensitive measurement of body composition 
than BMI (26,27). Furthermore, waist circumference (WC) describes fat distribution and 
correlates more strongly with visceral fat than BMI (28–30). 
 
Sero-positive and sero-negative RA differ in their phenotype, susceptibility genes and impact 
of smoking as a risk factor (2,31). Therefore, it is important to investigate the association 
between possible risk factors and the development of sero-positive and sero-negative RA 
separately. However, some patients who are initially sero-negative at presentation, later 
become sero-positive (32), indicating that this distinction may not be optimal. Thus, 
reporting associations for three groups: ‘overall RA’, ‘sero-positive RA’, and ‘other RA’ 
provides the most legitimate way to present the results, where ‘other RA’ includes patients 
who were initially sero-negative. 
 
The aim of our study was to examine the relationship between bioimpedance-derived total 
body fat percentage, WC and BMI and the subsequent development of overall RA, sero-
positive RA and other RA.  
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SUBJECTS AND METHODS 
Setting  
The study was a population-based prospective cohort study, conducted within the Danish 
Diet, Cancer and Health cohort (33). 
 
Data sources 
The Danish Diet, Cancer and Health cohort. In the period between 1993 and 1997, a total of 
160,725 persons aged 50-64 years were invited to participate in the cohort. Eligible cohort 
participants were born in Denmark, living in the Copenhagen or Aarhus Counties, and had 
no previous cancer diagnosis recorded in the Danish Cancer Registry (34). All eligible 
persons received an invitation containing information about the cohort study. In total, 
57,053 persons accepted the invitation. Detailed information about lifestyle factors, 
socioeconomic status, anthropometric measures, including bio-impedance, were collected 
at enrolment into the cohort. A detailed description of the Danish Diet, Cancer and Health 
cohort has been published previously (33).    
The Danish Civil Registration System contains information about date of birth, place of 
residence, vital status and migration into or out of Denmark since 1968. The system is 
continuously updated and ensures complete follow-up regarding vital and migration status 
of all Danish citizens (35).  
The Danish National Patient Registry contains data about all admissions to somatic hospitals 
in Denmark since 1977 and all out-patient attendances since 1995 (36), including dates of 
hospital admissions, ward types, discharge diagnoses, dates of all attendances at out-
patient clinics, and diagnoses recorded at each attendance. The diagnoses have been 
classified in accordance with the Danish version of the International Classification of 
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Diseases 8th edition (ICD-8) until the end of 1993 and thereafter in accordance with the 
updated version, ICD-10 (37).  
The Danish National Prescription Registry contains information about all prescription drugs 
dispensed at Danish community pharmacies since 1994 (38). The Registry does not include 
information about drugs dispensed by hospital pharmacies directly to in-patients or out-
patients. 
 
Data linkage 
The Danish Diet, Cancer and Health cohort baseline data were linked to the Danish Civil 
Registration System (35) and the Danish National Patient Registry (36) on the 14th October 
2016 and to the Danish National Prescription Registry (38) on the 14th December 2016, using 
the unique Civil Personal Registration (CPR) number. This number is used in all Danish 
registries enabling data linkage across all of them at the individual level. 
 
Study population  
All participants from the Danish Diet, Cancer and Health cohort without a previous RA 
diagnosis recorded in the Danish National Patient Registry prior to their enrolment into the 
cohort and who had no missing data on exposure variables or covariates were included in 
our study. Persons registered with diagnostic codes related to autoimmune diseases other 
than RA were not excluded. 
 
Exposure  
Anthropometric measures were taken in a standardized manner by trained persons at the 
enrolment into the Danish Diet, Cancer and Health cohort (33,39). The following exposure 
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variables, describing baseline body characteristics were used in our study: height (cm), 
weight (kg), BMI (kg/m2), WC (cm) and bioelectrical impedance-derived total body fat 
percentage (%). 
Height was measured with the participants standing without shoes and was recorded to the 
nearest 0.5 cm. Weight was measured using a digital scale, with the participants wearing 
light clothing or underwear, and was recorded to the nearest 100 g. WC was measured at 
the narrowest part between the lower rib and the iliac crest (the natural waist) or, in case of 
an indeterminable waist narrowing, halfway between the lower rib and the iliac crest, and 
was recorded to the nearest 0.5 cm. 
For bioelectrical impedance, non-fasting measurements were performed using a four-
electrode BIA 101-F device (Akern/RJL, Florence Italy). The bioelectrical impedance method 
had previously been validated in a Danish population using a four-compartment-model 
based on measurements of both total body potassium (whole body counting) and total body 
water (dilutometry) as a gold standard (40).   
 
Outcome 
The outcome of interest was the development of RA. Incident RA cases were identified 
through the Danish National Patient Registry (36). The following ICD-10 codes were used: 
M05 (sero-positive RA) and M06 (other RA), if recorded as a primary or a secondary 
diagnosis. Referral diagnoses were not used. Patients, who were registered with one of 
“M05” diagnostic codes at the first registration, were defined as having sero-positive RA and 
patients registered with one of “M06” diagnostic codes – as having ‘other RA’. After the 
study entry, no patients were registered with ICD-8 codes for RA in the Danish National 
Patient Registry.  In order to increase the positive predictive value of the RA diagnosis in the 
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Registry, data were also linked with the Danish National Prescription Registry. Thus, incident 
RA cases in our study were defined as patients with their first RA diagnosis in the Danish 
National Patient Registry after the enrolment into the Danish Diet, Cancer and Health 
cohort, who had subsequently, at least once, redeemed a prescription for a synthetic 
Disease Modifying Anti-Rheumatic Drug (sDMARD). The following Anatomical Therapeutic 
Chemical (ATC) codes(41) from the Danish National Prescription Registry were retrieved: 
Methotrexate (ATC: L01BA01, L04AX03), Sulfasalazine (ATC: A07EC01), Azathioprine (ATC: 
L04AX01), Hydroxychloroquine (ATC: P01BA02) and Leflunomide (ATC: L04AA13). 
 
Covariates 
At the time of enrolment into the Danish Diet, Cancer and Health cohort, the participants 
completed a comprehensive questionnaire, covering their health, education, occupation, 
lifestyle and reproductive factors and a semi-quantitative food frequency questionnaire, 
whose development and validation has been described previously (42,43). The 
questionnaires were scanned immediately, and missing answers were filled in during an 
interview at the clinic. Information about smoking status (current, past or never), smoking 
duration (years), current tobacco consumption (grams per day), and time since smoking 
cessation (years) were collected. Current tobacco consumption was calculated in grams per 
day using conversion factors of 1 for cigarettes, 4.5 for cigars and 3 for cheroots or pipe. 
Dietary information was obtained by a detailed, 192-item food-frequency questionnaire, 
which study participants had received by mail before their visit to the study clinic.  The 
participants were asked to report their average intake of different food and beverage items 
over the past 12 months within 12 possible categories ranging from never to 8 times or 
more per day. Daily intake of specific foods and nutrients was calculated for each participant 
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using the software program FoodCalc (33), using specifically developed standardized recipes 
and portion sizes. Alcohol intake was reported for 6 different types of alcoholic beverages: 
light, regular or strong beer (in bottles), wine (in glasses), fortified wine (in drinks), spirits (in 
drinks) in predefined categories from never to 8 or more drinks per day. The alcohol content 
for each type was summed up, and daily amount (gram) of alcohol intake was calculated. 
Physical activity during the past year was assessed from questions about average number of 
hours per week spent on leisure-time activities (walking, gardening, housework, home 
maintenance, sports, biking) and work activities. Physical activity was quantified in 
Metabolic Equivalent of Task (MET) hours per week. Self-reported length of education was 
collected in predefined categories (primary school, higher education 1-2 years, higher 
education 3-4 years, higher education more than 4 years). 
 
Statistical analyses 
For descriptive statistics, we reported medians with Interquartile Range (IQR) and 
percentages for discrete variables separately for men and women. The associations 
between each exposure (bioimpedance-derived total body fat percentage, WC, BMI) and 
the development of overall RA, sero-positive RA and other RA  were examined using Cox´s 
proportional hazards regression models with delayed entry and age as the underlying time 
variables (44) separately for men and women. The dose-response associations were 
elucidated using Cox regression models with restricted cubic splines.  
The participants were followed until development of RA, death, loss to follow-up, or 
October 2016, whichever came first.  
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Total body fat percentage was entered into the models as a continuous variable in two ways 
– per 5% increment in the main analysis and per 1% increment in the dose-response 
analysis. WC was entered as a continuous and as a categorical variable. As a continuous 
variable, WC was entered into the models in two ways - per 5cm increment in the main 
analysis and per 1cm increment in the dose-response analysis. As a categorical variable, WC 
was grouped into non-abdominal obese and abdominal obese categories, using 
recommended WHO cut-off values for men/women of >102/>88 cm for abdominal obesity 
(45,46). BMI was entered as a continuous (per 1-unit kg/m2 increment) and as a categorical 
variable. BMI was categorized according to the World Health Organization (WHO) into 
underweight (<18.5 kg/m2), normal weight (18.5-24.99 kg/m2), overweight (25-29.99 kg/m2) 
and obese (≥30 kg/m2) groups (45,46). Non-abdominal obese and normal weight persons 
were entered as reference groups (45,46). All results were further reported as linear 
function hazards ratios with 95% confidence intervals (CI). 
 
All analyses were performed stratifying by sex, first as univariate analyses (age-adjusted), 
then adjusting for age and smoking (status (never, former, current), duration, tobacco g/d) 
and, finally, as multivariate analyses, adjusting for age, smoking (status, duration, tobacco 
g/d), alcohol consumption (g/year), educational level (primary school, higher education 1-2 
years, higher education 3-4 years, higher education >4 years), overall physical activity, 
measured as the Metabolic Equivalent of Task (MET, hours per week) (47), and total intake 
of n-3 fatty acids (g/d), as potential confounders. 
 
Analyses were performed using Stata, version 14.2, College Station, Texas, USA. 
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RESULTS 
A total of 57,053 persons consented to participate in the Danish Diet, Cancer and Health 
cohort study. Due to the registration delay in the Danish Cancer Registry, 578 persons were 
erroneously included in the cohort study, as they had been diagnosed with cancer before 
the enrolment.  Among the remaining 56,475 persons, 289 persons were excluded due to 
RA diagnoses registered in the Danish National Patient Registry at or prior to baseline and 
1,149 persons due to missing data.  Thus, a total of 55,037 participants (26,317 men and 
28,720 women) with complete data and no previous RA diagnosis in the Danish National 
Patient Registry were included into our cohort study.   
 
The median (IQR) duration of follow-up was 20.1 (19.5-20.9) years. During 1,023,558 
person-years of follow-up, 666 individuals (210 men and 456 women) developed RA. The 
median (IQR) time to onset of RA was 10.8 years (6.1-15.6) and the median (IQR) age at RA 
onset was 68.0 (62.7-74.0) years for men and 67.8 (62.1-72.2) years for women.  Table 1 
shows the baseline characteristics of the total cohort and RA cases by gender.  
At baseline, no major differences in anthropometric measures were found between the 
total cohort and cases, except that female RA cases were more likely to be overweight and 
obese, than the female cohort (54% vs. 49%, respectively). In both genders, more smokers 
were found among RA cases (Table 1).   
 
Table 2 shows the sex-specific hazard ratios (HR) for the associations between 
anthropometric measures and overall incident RA. In women, higher fat percentage was 
associated with a higher risk of developing RA (HR 1.10 per 5% increment; 95% CI 1.02-
1.18). Further, positive associations were also seen for higher WC (HR 1.05 per 5cm 
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increment; 95% CI 1.01-1.10), abdominal obesity (HR 1.18; 95% CI 0.96-1.45) compared to 
non-abdominal obesity, and BMI-defined obesity (HR 1.46; 95% CI 1.12-1.90) compared to 
normal weight. In men, there was no clear association between the anthropometric 
measures and the development of overall RA.  
Post hoc sensitivity analyses were performed, using additional criteria in determining RA 
cases - patients with their first RA diagnosis in the Danish National Patient Registry after the 
enrolment into the Danish Diet, Cancer and Health cohort, who had subsequently, at least 
once, redeemed a prescription for a sDMARD and who had no ICD code for psoriatic or 
enteropathic arthropathies (ICD-8: 696.0; ICD-10: M07), systemic connective tissue 
disorders (ICD-8: 446, 716, 734; ICD-10: M30-M35), inflammatory bowel diseases (ICD-8: 
563; ICD-10: K50-K51) or sarcoidosis (ICD-8: 135.99; ICD-10: D86) in the previous or 
following years in the Danish National Patient Registry. Excluding these diagnoses did not 
alter the results substantially (Supplementary Table 1). Furthermore, post hoc subanalyses 
stratifying by smoking status (current and never) were performed. The positive associations 
between BMI, WC, fat percentage and the risk of developing RA were maintained in both 
groups (Supplementary Table 2 and 3).  
 
The results for the sero-positive RA patients are presented in Table 3. In both genders there 
was no clear association between the anthropometric measures and the development of 
sero-positive RA.  
 
Table 4 shows the associations between each exposure of interest and the development of 
‘other RA’. In women, higher fat percentage was associated with a higher risk of other RA 
(HR 1.14 per 5% increment; 95% CI 1.04-1.25). Positive associations were also seen for 
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higher WC (HR 1.08 per 5cm increment; 95% CI 1.03-1.13), abdominal obesity (HR 1.30; 95% 
CI 1.00-1.70), overweight (HR 1.38; 95% CI 1.05-1.80) and obesity (HR 1.74; 95% CI 1.25-
2.43). Among men, there was no association between fat percentage, WC or BMI and the 
development of ‘other RA’.  
Additional adjustment for potential confounders including alcohol consumption, 
educational level, physical activity and total intake of n-3 fatty acids did not change the 
results substantially (Tables 2-4).  
Spline graphs of dose-response associations between the anthropometric measures and 
overall RA, sero-positive RA and ‘other RA’ risk in men and women can be found in Figure 1 
and 2 and Supplementary Figures 1 and 2. There was a clear positive association between 
BMI, WC, fat percentage and the risk of developing ´overall RA´ and ´other RA´ in women. 
There was a weak positive association between high values of anthropometric 
measurements and the risk of developing ´overall RA´, ´sero-positive RA´ and ´other RA´ in 
men and ´sero-positive RA` in women. 
To analyze the relationship between BMI and bioelectrical impedance-derived body fat 
percentage, the Pearsons’ correlation coefficient (r) was calculated. There was a strong 
correlation between BMI and body fat percentage both in men (r=0.88, p<0.001) and in 
women (r=0.91, p<0.001). Scatter plots of the associations can be found in Supplementary 
Figure 3. 
 
DISCUSSION 
In this large population-based prospective cohort study, we observed that having higher 
body fat percentage, higher WC, being overweight (BMI 25-29.99 kg/m2) or obese (BMI≥30 
kg/m2) was associated with a higher risk of ´overall RA´ and ‘other RA’ risk in women. We 
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found that overall RA risk was 10% higher for each 5% increment of total body fat in 
women. Women with a high WC were more likely to develop RA, than those with a low WC 
(5% higher risk for each 5cm increment of WC). Furthermore, obese women had nearly 50% 
higher risk of developing RA, than women with a normal BMI. We found weak positive 
associations between high values of the anthropometric measures and the development of 
RA in men and ´sero-positive RA` in women.  
We found no previous studies exploring associations between bioimpedance-derived fat 
percentage, WC and RA risk. Our findings are in line with most of the previous studies 
investigating the associations between BMI and RA risk (11,12,15,19–22). We have, 
however, abstained from categorizing RA into sero-positive and sero-negative RA as it is 
well-known, that some sero-negative RA patients become sero-positive during the disease 
course (32). Further, some sero-negative patients may be misclassified as having RA, i.e. 
some of these patients might be obese and have osteoarthritis (48), psoriatic arthritis, 
polyarticular gout or fibromyalgia. Furthermore, proinflammatory activity in fat tissue and 
concomitant joint pain, as a part of osteoarthritis or fibromyalgia, may have led to the 
diagnosis of inflammatory arthritis. Therefore, in our study, we have defined three RA 
groups: overall RA, sero-positive RA and other RA. 
 
The majority of studies, investigating the associations between BMI and the risk of 
serological subsets of RA, found obesity to be associated with the development of sero-
negative RA (15,19,20,22). Only one study based on the Nurses’ Health Study found obesity 
to be positively associated with sero-positive RA, and only among women diagnosed at age 
55 years or younger (20). A large UK population-based prospective cohort study, the EPIC-
Norfolk study, observed a nearly threefold higher risk of sero-negative (baseline RF and 
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ACPA negative) inflammatory polyarthritis in persons with obesity compared to normal 
weight persons (22). Two Scandinavian case-control studies yielded similar results (15,19). 
An association between obesity and the development of sero-negative RA was, however, 
not found in an American case-control study, which included 813 newly diagnosed RA 
patients (17). Two Swedish nested case-control studies, based on the Malmo Diet Cancer 
Study and the Malmo Preventive Medicine Project were also unable to establish this 
association (23). The inconsistency in the results could be explained by methodological 
differences between the studies, including data collection, a low number of sero-negative 
RA cases and possible misclassification of RA, especially sero-negative RA. The gender 
differences in our findings are similar to those of the Swedish case-control study (19). The 
findings might be explained by a different hormonal activity in men and women (49) or even 
by different pain responses (50) and hereby potential higher risk for RA misclassification in 
women.  
  
The strengths of our study include the population-based prospective cohort study design 
with 20 years follow-up period and a large number of outcomes. The study included 
validated and detailed information on multiple body composition measures and covariates. 
Anthropometric measurements were obtained by a trained laboratory technician in a 
standardized manner, ensuring the reliability of the estimates (40). Detailed information on 
a range of already established and potential confounding factors was available for the study. 
However, adjusting for potential confounding factors in the analysis had only minor impact 
on the estimated hazard ratios. Only a minor number of participants in the Danish Diet, 
Cancer and Health cohort had missing data on any of exposure or any of the co-variates and 
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therefore they were not included in our study, allowing us to conduct the complete-case 
analysis. 
Further, the Danish health system, is an uniformly organized, non-profit system, having near 
complete follow-up and enabling data linkage between population-based registries on the 
individual level. 
 
We acknowledge the limitations of our study. Our study population consists only of 
Caucasian persons, the results may not be generalizable to other populations. Non-response 
to participate in the Danish Diet, Cancer and Health cohort could potentially have been 
related to the exposure, but not to the outcome (RA) because of the prospective study 
design. Virtually no loss to follow-up limits the possibility of response bias. Another 
limitation is the relatively low numbers of RA cases in men and ´sero-positive RA´ in women. 
It might be due to the age limit in our cohort and use of data from an administrative 
database. We might be underpowered to detect a true association in these groups due to 
the low numbers of events. Furthermore, in our study we used the baseline anthropometric 
measurements. Changes in body fat over time might have a different effect on the RA risk, 
which we were not able to analyze. Finally, as a consequence of the age limit in our cohort, 
we were unable to investigate the potential association of body composition and RA risk in 
persons younger than 50 years.   
The association results between different anthropometric measurements and the risk of RA 
are consistent, reflecting the strong correlation between BMI and bioelectrical impedance-
derived body fat percentage. Thus, in our study, BMI seems to be an adequate surrogate 
measure for body fat percentage.  
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In conclusion, a higher body fat percentage, higher waist circumference and obesity were 
associated with a higher risk of ´overall RA´ and ´other RA´ in women, indicating that excess 
total body fat volume per se rather than abdominal obesity is associated with RA risk. It 
remains unknown whether the association of the development of RA with excess adipose 
tissue simply reflects the presence of inflammatory activity as a part of the metabolic 
syndrome or whether it contributes to the development of autoimmune inflammatory joint 
disease. 
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Table 1. Baseline demographic, anthropometric and lifestyle characteristics of all participants in the Danish 
Diet, Cancer and Health cohort and of those who developed RA, by gender 
 
Men Women 
Cohort 
(n=26,317) 
RA cases (n=210) Cohort 
(n=28,720) 
RA cases (n=456) 
Age, years 56 (53-60) 57 (53-61) 56 (53-61) 57 (53-61) 
Height, cm 177 (172-181) 176 (172-180) 164 (160-168) 165 (161-169) 
Weight, kg 82 (75-90) 82 (74-89) 67 (61-75) 69 (61-77) 
BMI, kg/m2 26 (24-29) 26 (24-29) 25 (23-28) 25 (23-28) 
BMI grouped according  
to WHO 
    
      Underweight, %  
      (<18.5 kg/m2)       
0 0 1 1 
      Normal weight, % 
      (18.5-24.9 kg/m2) 
34 37 50 45 
      Overweight, % 
      (25-29.9 kg/m2) 
50 47 35 37 
      Obese, % 
      (≥30 kg/m2) 
16 16 14 17 
Waist circumference, cm 95 (89-102) 95 (88-101) 80 (74-88) 81 (75-90) 
Abdominal obesity* 
        Yes, % 
        No, % 
 
23 
77 
 
24 
76 
 
25 
75 
 
27 
73 
Fat percentage 27 (23-30) 27 (23-30) 35 (30-39) 36 (31-40) 
Educational level     
     Primary school, % 10 10 19 22 
     Higher education, 
      1-2 years, % 
14 15 32 35 
     Higher education, 
       3-4 years, % 
42 43 38 34 
     Higher education, 
       >4 years, % 
34 32 11 9 
Smoking status     
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     Never smoker, % 26 20 44 32 
     Former smoker, % 34 34 23 23 
     Current smoker, % 40 46 33 45 
Total tobacco     consumption 
for current smokers 
    
      <15 g per day, % 27 25 47 48 
     15-25 g per day, % 49 54 49 49 
      >25 g per day, % 24 21 4 3 
Alcohol, g per day 19 (11-40) 19 (8-37) 9 (3-17) 9 (3-18) 
MET score, hours/week 54 (35-83)   57 (37-89) 59 (39-87) 55 (36-84) 
Total intake of n-3 fatty acids, 
g/d  
2.8 (2.2-3.6) 2.8 (2.2-3.6) 2.2 (1.7-2.8) 2.1 (1.7-2.7) 
Medians (interquartile range) for continuous variables. 
BMI – Body Mass Index, WHO – World Health Organization, WC – Waist Circumference, MET – Metabolic 
Equivalent of Task  
* Abdominal obesity according to WHO recommended cut-off values: WC > 102 cm for men, WC > 88 cm for 
women. 
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Table 2. The relationship between anthropometric measures and the development of overall RA* by 
gender 
 
 
  
Cox proportional Hazard Ratio (95% confidence interval) 
Overall RA* men  
(number of cases = 210) 
Overall RA* women  
(number of cases = 456) 
Age- and 
smoking-
adjusted1 
Multivariable-
adjusted2 
Age- and 
smoking-
adjusted1 
Multivariable-
adjusted2 
BMI, per 1-unit kg/m2 1.01 (0.97–1.05) 1.01 (0.98–1.05) 1.03 (1.01–1.05) 1.03 (1.01–1.05) 
BMI < 18.5 kg/m2 
BMI 18.5 – 24.99 kg/m2 
BMI 25 – 29.99 kg/m2 
BMI ≥ 30 kg/m2 
N/A 
1 (ref.) 
 
0.87 (0.64–1.17) 
1.01 (0.67–1.53) 
N/A 
1 (ref.) 
 
0.87 (0.65–1.18) 
1.04 (0.69–1.57) 
0.59 (0.19–1.83) 
1 (ref.) 
 
1.22 (1.00–1.50) 
1.46 (1.12–1.90) 
0.58 (0.19–1.83) 
1 (ref.) 
 
1.20 (0.98–1.48) 
1.40 (1.08–1.83) 
WC, per 5 cm increment 1.02 (0.95–1.09) 1.03 (0.96–1.10) 1.05 (1.01–1.10) 1.05 (1.01–1.09) 
Abdominal obesity3 
No 
Yes 
 
1 (ref.) 
1.15 (0.84-1.57) 
 
1 (ref.) 
1.18 (0.86–1.63) 
 
1 (ref.) 
1.18 (0.96-1.45) 
 
1 (ref.) 
1.15 (0.93-1.42) 
Fat percentage, 
per 5% increment 
1.02 (0.90–1.16) 1.03 (0.90–1.17) 1.10 (1.02–1.18) 1.08 (1.01–1.16) 
*Patients, who were registered with one of ICD-10 “M05” or “M06” diagnostic codes at their first 
registration in the Danish National Patient Registry 
BMI – Body Mass Index, WC – Waist Circumference 
1Adjusted for age and smoking (status, duration, tobacco g/day) 
2Adjusted for age, smoking (status, duration, tobacco g/day), socio-economic status (education level), 
alcohol consumption (g/day), physical activity (Metabolic Equivalent of Task, hours/week) and total intake of 
n-3 fatty acids (g/day) 
3Abdominal obesity according to WHO recommended cut-off values: WC > 102 cm for men, WC > 88 cm for 
women 
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Table 3. The relationship between anthropometric measures and the development of sero-positive RA*, by 
gender 
 
 
  
Cox proportional Hazard Ratio (95% confidence interval) 
Seropositive RA* men  
(number of cases = 79)  
Seropositive RA* women 
 (number of cases = 187) 
Age- and smoking-
adjusted1 
Multivariable-
adjusted2 
Age- and smoking-
adjusted1 
Multivariable-
adjusted2 
BMI, per 1-unit kg/m2 1.01 (0.95–1.08) 1.02 (0.96–1.10) 1.01 (0.97–1.04) 1.00 (0.97–1.04) 
BMI < 18.5 kg/m2 
BMI 18.5 – 24.99 kg/m2 
BMI 25 – 29.99 kg/m2 
BMI ≥ 30 kg/m2 
N/A 
1 (ref.) 
 
0.94 (0.57–1.53) 
1.00 (0.51-1.98) 
N/A 
1 (ref.) 
 
0.98 (0.60–1.61) 
1.12 (0.56–2.22) 
0.85 (0.21–3.47) 
1 (ref.) 
 
1.04 (0.75–1.42) 
1.12 (0.73–1.73) 
0.83 (0.20–3.38) 
1 (ref.) 
 
1.01 (0.73–1.39) 
1.04 (0.68–1.61) 
WC,  
per 5 cm increment 
1.02 (0.91–1.14) 1.05 (0.93–1.17) 1.01 (0.95–1.08) 1.01 (0.94–1.07) 
Abdominal obesity3 
No 
Yes 
 
1 (ref.) 
0.89 (0.51–1.54) 
 
1 (ref.) 
0.97 (0.56–1.69) 
 
1 (ref.) 
1.01 (0.73–1.42) 
 
1 (ref.) 
0.98 (0.70–1.37) 
Fat percentage, 
per 5% increment 
1.04 (0.84–1.29) 1.08 (0.88–1.34) 1.03 (0.93–1.15) 1.01 (0.91–1.13) 
*Patients, who were registered with one of ICD-10 “M05” diagnostic codes at their first registration in the 
Danish National Patient Registry 
BMI – Body Mass Index, WC – Waist Circumference 
1Adjusted for age and smoking (status, duration, tobacco g/day) 
2Adjusted for age, smoking (status, duration, tobacco g/day), socio-economic status (education level), alcohol 
consumption (g/day), physical activity (Metabolic Equivalent of Task, hours/week) and total intake of n-3 fatty 
acids (g/day) 
3Abdominal obesity according to WHO recommended cut-off values: WC > 102 cm for men, WC > 88 cm for 
women 
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Table 4. The relationship between anthropometric measures and the development of other RA* by gender 
 
 
  
Cox proportional Hazard Ratio (95% confidence interval) 
Other RA* men  
(number of cases = 131)  
Other RA* women  
(number of cases = 269) 
Age- and smoking-
adjusted1 
Multivariable-
adjusted2 
Age- and smoking-
adjusted1 
Multivariable-
adjusted2 
BMI, per 1-unit kg/m2 1.01 (0.96–1.06) 1.01 (0.96–1.06) 1.04 (1.02–1.07) 1.04 (1.0–1.07) 
BMI < 18.5 kg/m2 
BMI 18.5 – 24.99 kg/m2 
BMI 25 – 29.99 kg/m2 
BMI ≥ 30 kg/m2 
N/A 
1 (ref.) 
 
0.83 (0.57–1.20) 
1.02 (0.61–1.71) 
N/A 
1 (ref.) 
 
0.81 (0.56–1.19) 
1.00 (0.59–1.67) 
0.36 (0.05–2.57) 
1 (ref.) 
 
1.38 (1.05–1.80) 
1.74 (1.25–2.43) 
0.36 (0.05–2.60) 
1 (ref.) 
 
1.37 (1.05–1.79) 
1.70 (1.22–2.39) 
WC,  
per 5 cm increment 
1.02 (0.93–1.11) 1.02 (0.93–1.11) 1.08 (1.03-1.13) 1.08 (1.02-1.13) 
Abdominal obesity3 
No 
Yes 
 
1 (ref.) 
1.32 (0.89–1.94) 
 
1 (ref.) 
1.31 (0.89–1.94) 
 
1 (ref.) 
1.30 (1.00–1.70) 
 
1 (ref.) 
1.28 (0.98–1.67) 
Fat percentage, 
per 5% increment 
1.00 (0.85–1.18) 1.00 (0.85–1.18) 1.14 (1.04–1.25) 1.13 (1.03–1.24) 
*Patients, who were registered with one of ICD-10 “M06” diagnostic codes at their first registration in the Danish 
National Patient Registry 
BMI – Body Mass Index, WC – Waist Circumference 
1Adjusted for age and smoking (status, duration, tobacco g/day) 
2Adjusted for age, smoking (status, duration, tobacco g/day), socio-economic status (education level), alcohol 
consumption (g/day), physical activity (Metabolic Equivalent of Task, hours/week) and total intake of n-3 fatty 
acids (g/day) 
3Abdominal obesity according to WHO recommended cut-off values: WC > 102 cm for men, WC > 88 cm for 
women 
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Figure 1. Dose-response associations between body fat percentage and risk for development of 
overall1 RA for persons enrolled in the Danish Diet, Cancer and Health cohort by gender. Four knots 
spline graphs, solid lines showing age and smoking adjusted (*) Cox proportional Hazard Ratio`s (HR) 
per 1% increment of total body fat and dash lines showing 95% confidence intervals. 
 
            
 
1 Patients, who were registered with one of ICD-10 “M05” or “M06” diagnostic codes at their first 
registration in the Danish National Patient Registry 
* Adjusted for age and smoking (status, duration, tobacco g/day).  
RA – Rheumatoid Arthritis, ICD – International Classification of Diseases 
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Figure 2. Dose-response associations between body fat percentage and risk for development of sero-
positive1 RA and other2 RA for persons enrolled in the Danish Diet, Cancer and Health cohort by 
gender. Four knots spline graphs, solid lines showing age and smoking adjusted (*) Cox proportional 
Hazard Ratio`s (HR) per 1% increment of total body fat and dash lines showing 95% confidence 
intervals. 
 
 
 
1 Patients, who were registered with one of ICD-10 “M05” diagnostic codes at their first registration 
in the Danish National Patient Registry 
2 Patients, who were registered with one of ICD-10 “M06” diagnostic codes at their first registration 
in the Danish National Patient Registry 
* Adjusted for age and smoking (status, duration, tobacco g/day) 
RA – Rheumatoid Arthritis, ICD – International Classification of Diseases  
